Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.Da3GqCks.js ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and 4D Molecular Therapeutics (FDMT)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and ...
Globus Medical strengthens SCS market position with $250m Nevro deal
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
medtechdive22h
M&A and a separation take center stage in latest earnings season
BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...